LPL Financial LLC

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 1403438 FORT MILL, SC

Position in ARQT

as of Mar 31, 2026 · filed May 6, 2026 Compact

Position Value

$2,812,616

-$436,204 QoQ

Shares Held

119,381

+6.7% QoQ

Ownership

0.095%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 0.955763479950746.ToString("F0")% Shared 0.ToString("F0")% None 99.04423652004925.ToString("F0")%

Healthcare · as of Mar 31, 2026

LPL Financial LLC holds $464,981,245 across 201 Biotechnology names. ARQT ranks #27 (0.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	268,062	$119,700,405
2	REGN	Regeneron Pharmaceuticals, Inc.	63,987	$49,438,915
3	INSM	INSMED Inc	138,281	$22,611,709
4	ALNY	Alnylam Pharmaceuticals, Inc.	67,637	$22,379,054
5	EXEL	Exelixis, Inc.	399,612	$17,139,358
6	ARGX	Argenx SE	23,247	$16,976,121
7	HALO	Halozyme Therapeutics, Inc.	194,304	$12,557,867
8	ROIV	Roivant Sciences Ltd.	378,656	$10,488,771

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$2,812,616	119,381	+6.7%	Shares	Sole	2026-05-06
2025-12-31	$3,248,820	111,874	-4.3%	Shares	Sole	2026-02-11
2025-09-30	$2,204,017	116,924	-3.9%	Shares	Sole	2025-11-12
2025-06-30	$1,705,070	121,617	+5.1%	Shares	Sole	2025-08-12
2025-03-31	$1,810,439	115,757	-4.2%	Shares	Sole	2025-05-07
2024-12-31	$1,684,025	120,892	-4.3%	Shares	Sole	2025-02-11
2024-09-30	$1,174,404	126,280	-15.6%	Shares	Sole	2024-11-08
2024-06-30	$1,390,722	149,540	-5.5%	Shares	Sole	2024-08-07
2024-03-31	$1,567,811	158,205	-16.6%	Shares	Sole	2024-05-10
2023-12-31	$612,546	189,643	+127.1%	Shares	Sole	2024-02-14
2023-09-30	$443,454	83,513	+141.5%	Shares	Sole	2023-11-13
2023-06-30	$329,566	34,582	—	Shares	Sole	2023-07-31
No filing history on record for this holder in this stock.